Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population

Background: Patients with diabetic kidney disease (DKD) are at increased risk for cardiovascular events but traditional risk factors do not fully explain this association. Evaluation of subclinical vascular disease might improve risk stratification and management of these patients. The aim of the st...

Full description

Bibliographic Details
Main Authors: Christodoula Kourtidou, Vasileios Rafailidis, Garyfallia Varouktsi, Efthimios Kanakis, Vassilios Liakopoulos, Timoleon-Achilleas Vyzantiadis, Maria Stangou, Smaragdi Marinaki, Konstantinos Tziomalos
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/12/7/1139
_version_ 1797433389541752832
author Christodoula Kourtidou
Vasileios Rafailidis
Garyfallia Varouktsi
Efthimios Kanakis
Vassilios Liakopoulos
Timoleon-Achilleas Vyzantiadis
Maria Stangou
Smaragdi Marinaki
Konstantinos Tziomalos
author_facet Christodoula Kourtidou
Vasileios Rafailidis
Garyfallia Varouktsi
Efthimios Kanakis
Vassilios Liakopoulos
Timoleon-Achilleas Vyzantiadis
Maria Stangou
Smaragdi Marinaki
Konstantinos Tziomalos
author_sort Christodoula Kourtidou
collection DOAJ
description Background: Patients with diabetic kidney disease (DKD) are at increased risk for cardiovascular events but traditional risk factors do not fully explain this association. Evaluation of subclinical vascular disease might improve risk stratification and management of these patients. The aim of the study was to compare the prevalence of markers of arterial stiffness, carotid atherosclerosis and peripheral arterial disease between patients with DKD and patients with type 2 diabetes mellitus (T2DM) and preserved kidney function. Methods: We prospectively enrolled patients with DKD and age- and gender-matched patients with T2DM but without DKD (estimated glomerular filtration rate < and ≥60 mL/min/1.73 m<sup>2</sup>, respectively). The presence of arterial stiffness was evaluated by measuring pulse wave velocity (PWV), augmentation index (AIx), AIx adjusted to a heart rate of 75 beats/min (AIx@75) and central systolic, diastolic, pulse and mean blood pressure. The presence of carotid atherosclerosis was evaluated by measuring carotid stenosis, carotid intima-media thickness and maximal plaque thickness. The presence of PAD was evaluated with the measurement of ankle-brachial index (ABI). Results: Forty patients with T2DM were included in the study (mean age 71.6 ± 8.9 years). The prevalence of cardiovascular risk factors was similar in patients with and without DKD. PWV was higher in the former (9.8 ± 5.5 and 6.6 ± 4.4 m/s, respectively; <i>p</i> < 0.05) and carotid stenosis of the left carotid artery was also greater in patients with DKD (36.5 ± 12.6 and 22.1 ± 17.2%, respectively; <i>p</i> < 0.05). Other markers of arterial stiffness and carotid atherosclerosis and ABI did not differ between patients with DKD and those without DKD. Conclusions: Patients with DKD appear to have more pronounced arterial stiffness and carotid atherosclerosis than patients with T2DM and preserved kidney function despite the similar prevalence of traditional cardiovascular risk factors in the two groups. Therefore, evaluating the presence of subclinical vascular disease in these patients could be a useful tool for the personalization of their management.
first_indexed 2024-03-09T10:16:20Z
format Article
id doaj.art-616335f8fcae4810be595705c0b9b535
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-09T10:16:20Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-616335f8fcae4810be595705c0b9b5352023-12-01T22:20:46ZengMDPI AGJournal of Personalized Medicine2075-44262022-07-01127113910.3390/jpm12071139Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk PopulationChristodoula Kourtidou0Vasileios Rafailidis1Garyfallia Varouktsi2Efthimios Kanakis3Vassilios Liakopoulos4Timoleon-Achilleas Vyzantiadis5Maria Stangou6Smaragdi Marinaki7Konstantinos Tziomalos8First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, 54636 Thessaloniki, GreeceDepartment of Radiology, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 54636 Thessaloniki, GreeceDepartment of Nephrology, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 54636 Thessaloniki, GreeceFirst Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, 54636 Thessaloniki, GreeceDepartment of Nephrology, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 54636 Thessaloniki, GreeceFirst Department of Microbiology, Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceDepartment of Nephrology, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, 54642 Thessaloniki, GreeceDepartment of Nephrology and Renal Transplantation, Medical School, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, GreeceFirst Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, 54636 Thessaloniki, GreeceBackground: Patients with diabetic kidney disease (DKD) are at increased risk for cardiovascular events but traditional risk factors do not fully explain this association. Evaluation of subclinical vascular disease might improve risk stratification and management of these patients. The aim of the study was to compare the prevalence of markers of arterial stiffness, carotid atherosclerosis and peripheral arterial disease between patients with DKD and patients with type 2 diabetes mellitus (T2DM) and preserved kidney function. Methods: We prospectively enrolled patients with DKD and age- and gender-matched patients with T2DM but without DKD (estimated glomerular filtration rate < and ≥60 mL/min/1.73 m<sup>2</sup>, respectively). The presence of arterial stiffness was evaluated by measuring pulse wave velocity (PWV), augmentation index (AIx), AIx adjusted to a heart rate of 75 beats/min (AIx@75) and central systolic, diastolic, pulse and mean blood pressure. The presence of carotid atherosclerosis was evaluated by measuring carotid stenosis, carotid intima-media thickness and maximal plaque thickness. The presence of PAD was evaluated with the measurement of ankle-brachial index (ABI). Results: Forty patients with T2DM were included in the study (mean age 71.6 ± 8.9 years). The prevalence of cardiovascular risk factors was similar in patients with and without DKD. PWV was higher in the former (9.8 ± 5.5 and 6.6 ± 4.4 m/s, respectively; <i>p</i> < 0.05) and carotid stenosis of the left carotid artery was also greater in patients with DKD (36.5 ± 12.6 and 22.1 ± 17.2%, respectively; <i>p</i> < 0.05). Other markers of arterial stiffness and carotid atherosclerosis and ABI did not differ between patients with DKD and those without DKD. Conclusions: Patients with DKD appear to have more pronounced arterial stiffness and carotid atherosclerosis than patients with T2DM and preserved kidney function despite the similar prevalence of traditional cardiovascular risk factors in the two groups. Therefore, evaluating the presence of subclinical vascular disease in these patients could be a useful tool for the personalization of their management.https://www.mdpi.com/2075-4426/12/7/1139type 2 diabetes mellitusdiabetic kidney diseasediabetic nephropathyarterial stiffnesspulse wave velocitycarotid atherosclerosis
spellingShingle Christodoula Kourtidou
Vasileios Rafailidis
Garyfallia Varouktsi
Efthimios Kanakis
Vassilios Liakopoulos
Timoleon-Achilleas Vyzantiadis
Maria Stangou
Smaragdi Marinaki
Konstantinos Tziomalos
Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population
Journal of Personalized Medicine
type 2 diabetes mellitus
diabetic kidney disease
diabetic nephropathy
arterial stiffness
pulse wave velocity
carotid atherosclerosis
title Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population
title_full Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population
title_fullStr Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population
title_full_unstemmed Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population
title_short Evaluation of Subclinical Vascular Disease in Diabetic Kidney Disease: A Tool for Personalization of Management of a High-Risk Population
title_sort evaluation of subclinical vascular disease in diabetic kidney disease a tool for personalization of management of a high risk population
topic type 2 diabetes mellitus
diabetic kidney disease
diabetic nephropathy
arterial stiffness
pulse wave velocity
carotid atherosclerosis
url https://www.mdpi.com/2075-4426/12/7/1139
work_keys_str_mv AT christodoulakourtidou evaluationofsubclinicalvasculardiseaseindiabetickidneydiseaseatoolforpersonalizationofmanagementofahighriskpopulation
AT vasileiosrafailidis evaluationofsubclinicalvasculardiseaseindiabetickidneydiseaseatoolforpersonalizationofmanagementofahighriskpopulation
AT garyfalliavarouktsi evaluationofsubclinicalvasculardiseaseindiabetickidneydiseaseatoolforpersonalizationofmanagementofahighriskpopulation
AT efthimioskanakis evaluationofsubclinicalvasculardiseaseindiabetickidneydiseaseatoolforpersonalizationofmanagementofahighriskpopulation
AT vassiliosliakopoulos evaluationofsubclinicalvasculardiseaseindiabetickidneydiseaseatoolforpersonalizationofmanagementofahighriskpopulation
AT timoleonachilleasvyzantiadis evaluationofsubclinicalvasculardiseaseindiabetickidneydiseaseatoolforpersonalizationofmanagementofahighriskpopulation
AT mariastangou evaluationofsubclinicalvasculardiseaseindiabetickidneydiseaseatoolforpersonalizationofmanagementofahighriskpopulation
AT smaragdimarinaki evaluationofsubclinicalvasculardiseaseindiabetickidneydiseaseatoolforpersonalizationofmanagementofahighriskpopulation
AT konstantinostziomalos evaluationofsubclinicalvasculardiseaseindiabetickidneydiseaseatoolforpersonalizationofmanagementofahighriskpopulation